DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Real-time Estimate Cboe BZX 03:34:04 2024-04-19 pm EDT 5-day change 1st Jan Change
141.9 USD -2.70% Intraday chart for DR Horton -6.50% -6.67%
Sales 2024 * 36.9B Sales 2025 * 39.3B Capitalization 48.17B
Net income 2024 * 4.72B Net income 2025 * 5.02B EV / Sales 2024 * 1.32 x
Net Debt 2024 * 715M Net Debt 2025 * 876M EV / Sales 2025 * 1.25 x
P/E ratio 2024 *
10.3 x
P/E ratio 2025 *
9.37 x
Employees 13,450
Yield 2024 *
0.82%
Yield 2025 *
0.88%
Free-Float 74.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.60%
1 week-5.99%
Current month-13.33%
1 month-8.63%
3 months-8.16%
6 months+40.87%
Current year-6.16%
More quotes
1 week
142.58
Extreme 142.58
154.26
1 month
142.58
Extreme 142.58
165.75
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Founder 74 77-12-31
Chief Executive Officer 54 98-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Founder 74 77-12-31
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
More insiders
Date Price Change Volume
24-04-19 141.9 -2.74% 2 140 681
24-04-18 145.9 +0.10% 5,503,894
24-04-17 145.7 -0.21% 3,183,255
24-04-16 146 -2.03% 3,085,836
24-04-15 149.1 -1.74% 2,736,548

Delayed Quote Nyse, April 19, 2024 at 02:19 pm EDT

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
145.9 USD
Average target price
167.6 USD
Spread / Average Target
+14.92%
Consensus